| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |